Description

4-Methyl-1-Oxa-4,9-Diazaspiro[5.5]Undecan-3-One CAS NO 84033-75-0 is a sophisticated spirocyclic heterocyclic compound featuring a unique oxadiazaspiro framework. This structure serves as a critical advanced pharmaceutical intermediate (API) and a versatile scaffold for medicinal chemistry, enabling the development of novel bioactive molecules. It is primarily utilized by research institutions and pharmaceutical companies engaged in the synthesis of central nervous system (CNS) agents, neurological disorder treatments, and other specialized therapeutic candidates.

Application

• Key Intermediate in Pharmaceutical Synthesis: Serves as a core building block for the development of novel drug candidates targeting neurological pathways.
• Medicinal Chemistry Research: Used as a privileged spirocyclic scaffold in structure-activity relationship (SAR) studies and lead optimization programs.
• CNS-Active Compound Development: Integral to the synthesis of potential therapeutics for disorders such as depression, anxiety, and cognitive impairment.
• Chemical Biology Probes: Employed in the design and synthesis of molecular probes to study biological targets and mechanisms.
• Custom Synthesis & Contract Manufacturing: Supplied for bespoke organic synthesis projects requiring high-purity, complex heterocycles.
• Academic & Industrial R&D: Used in exploratory chemistry for developing new chemical entities with potential pharmacological activity.

Basic Information

Product Name	4-Methyl-1-Oxa-4,9-Diazaspiro[5.5]Undecan-3-One
CAS No.	84033-75-0
Molecular Formula	C9H16N2O2
Molecular Weight	184.24 g/mol
Synonyms	4-Methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one; 1-Oxa-4,9-diazaspiro[5.5]undecan-3-one, 4-methyl-; 4-Methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one; Spiro[1-oxa-4,9-diazacycloundecane-3,1'-cyclopentane]-2-one, 4-methyl-; 84033-75-0; 4-Methyl-1-oxa-4,9-diazaspiro[5.5]undecane-3-one; 4-Methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (CAS 84033-75-0)
EINECS	Contact for details

Quality Control

Our production of 4-Methyl-1-Oxa-4,9-Diazaspiro[5.5]Undecan-3-One adheres to stringent quality protocols suitable for research and pharmaceutical intermediate applications. Each batch undergoes comprehensive analytical testing to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing specifications such as assay (by HPLC), related substances, and residual solvents are provided and available upon request. We support cGMP-compliant manufacturing for advanced projects.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single impurity	≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.